Evaluation of efficacy and safety of scalp threading with polydioxanone (PDO) monofilament threads in the treatment of male androgenetic alopecia | ||||
| Al-Azhar International Medical Journal | ||||
| Volume 2023, Issue 1, January 2023 | ||||
| DOI: 10.58675/2682-339X.2093 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Abdel Kareem IM1; Ibrahim MK1; Mahmoud E. Sherif2 | ||||
| 1Dermatology, Venerology and Andrology, Faculty of Medicine, Al-Azhar University | ||||
| 2Dermatology, enerology and Andrology, Faculty of Medicine, Ain Shams University | ||||
| Abstract | ||||
| Background: Male pattern baldness, known as androgenetic alopecia (AGA), is progressive hair loss. The degree of severity, age at onset, and location of hair loss of this polygenetic condition were varied. Polydioxanone (PDO) threads were used for facial rejuvenation, and becoming increasingly popular in hair growth. Aim: to determine polydioxanone monofilamet threads for male patients with crown baldness (vertex androgenetic alopecia) are safe and effective. Subject and Material: In this pilot study, 7 male AGA patients experiencing crown hair (stage III-vertex androgenetic alopecia by the Norwood-Hamilton scale). Polydioxanone monofilament threads were inserted into the dermal layer of the crown, or vertex, of the scalp. The result was evaluated after a half year by clinical assessment, computerized photograghy and trichoscopy examination. Results: Significant difference in hair regrowth and an increase in hair density after six months in the targeted area compared to the baseline of tricoscopy. The clinical result was favorable thanks to PDO threads. Conclusions: Scalp stringing with PDO monofilament strings is straightforward, possible and with quicker reassuring outcomes in male patients with crown sparseness (vertex androgenetic alopecia) with apparent expansion in hair thickness and thickness. | ||||
|
Statistics Article View: 20 |
||||
